University College London (UCL) Cancer Institute, London, United Kingdom.

Sanofi’s blockbuster ambitions for amlitelimab hit a bump in the road this morning with the news that the highest dose of the anti-OX40-ligand monoclonal antibody missed the main goal of a phase ...

Trove of potato genomes reveals genetic bottlenecks and past flirtations with wild varieties. Plus, scientists have used lasers to create the perception of a brand-new colour and physicists ...

In January, Sanofi agreed a $1.45 billion deal to acquire UK biotech Kymab and its lead drug KY1005, an OX40 antibody that like KHK4083 has already cleared a phase 2 trial in atopic dermatitis.

From China to Brazil to Germany, huge numbers of people are addicted to shopping, driven in part by companies that use gaming strategies ...

OX40 inhibitors may result in a shift in clinical practice due to their unique MOA. Credit: Kwangmoozaa / Shutterstock. With the recent developments in the atopic dermatitis (AD) market, the field is ...

Conversely, in dense urban environments dominated by built structures, introducing greenery becomes also increasingly vital, reintroducing nature into the so-called "concrete jungle." However ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial. Novartis ...

Molecular parameters governing antibody FcγR signaling and effector functions in the context of HIV envelope. Cell Reports , 2025; 44 (4): 115331 DOI: 10.1016/j.celrep.2025.115331 Cite This Page : ...

Different types of antibodies are produced by your immune system. These five antibodies help fight disease by detecting viruses, bacteria, and other pathogens (disease-causing microorganisms) and ...